| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 01/25/2007 | US20070021393 New use of GabaB receptor agonists |
| 01/25/2007 | US20070021345 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 01/25/2007 | US20070021332 Helminth-derived antigens having capacity of providing protection against parasites |
| 01/25/2007 | US20070020630 Methods of identifying compounds that target trna splicing endonuclease and uses of said compounds as anti-proliferative agents |
| 01/25/2007 | US20070020296 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/25/2007 | US20070020276 Methods for the treatment of carcinoma |
| 01/24/2007 | EP1744760A2 Pharmaceutical compositions for acute glucocorticoid therapy |
| 01/24/2007 | EP1503714A4 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/24/2007 | EP1280531B1 Formulation consisting of phentolamine mesylate and the use thereof |
| 01/24/2007 | EP1126823B1 A process for the preparation of sterile therapeutically acceptable beclomethasone dipropionate |
| 01/24/2007 | CN1902158A N,N-dihalogenated amino acids and derivatives |
| 01/24/2007 | CN1901911A Methods and compositions using thalidomide for the treatment and management of cancers and other diseases |
| 01/24/2007 | CN1901907A Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 01/24/2007 | CN1901903A Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901901A Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| 01/24/2007 | CN1901899A Methods of using and compositions comprising pde4 modulators for the treatment and management of asbestos-related diseases and disorders |
| 01/24/2007 | CN1901897A Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof |
| 01/24/2007 | CN1901895A Methods of treating cancer with hdac inhibitors |
| 01/24/2007 | CN1900087A Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 01/24/2007 | CN1296095C Improved mycoplasma hyopneumoniae bacterin vaccine |
| 01/24/2007 | CN1296051C New use of dextran sulfate |
| 01/24/2007 | CN1296043C Use of formula I Rapamycin compound in preparing pharmaceutical composition for treating solid tumor |
| 01/23/2007 | US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 01/23/2007 | US7166603 Dihydropyrimidone inhibitors of calcium channel function |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166235 Teeth cleaning, whitening using modified polysiloxane |
| 01/23/2007 | CA2348086C Controlled-release pharmaceutical formulations |
| 01/23/2007 | CA2332188C 5-(1-aminocyclohexyl)-2(1h)-pyridinone compounds and intermediates in the production thereof |
| 01/23/2007 | CA2215196C Liquid cleanser composition comprising an aqueous surfactant and a polymer containing hydrogel composition |
| 01/18/2007 | WO2007008080A2 Optical imaging contrast agents |
| 01/18/2007 | WO2006073748A3 Antibodies against antigen presenting cells and uses thereof |
| 01/18/2007 | WO2005016272A3 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders |
| 01/18/2007 | WO2005007112A3 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 01/18/2007 | WO2004087047A3 Mutants of replication competent vaccinia virus |
| 01/18/2007 | WO2004084837A3 Methods and compositions for treating and preventing inflammatory conditions |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | WO2004054510A3 Method for identifying modulators of human orexin-2 receptor |
| 01/18/2007 | US20070016968 Treatment of pain through expression of opioid receptors |
| 01/18/2007 | US20070016126 Treatment of age-related macular degeneration |
| 01/18/2007 | US20070015913 Mrp3 genes and uses thereof |
| 01/18/2007 | US20070015800 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 01/18/2007 | US20070015780 Method of treating cancer with azaspirane compositions |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070015746 Azepine derivaties as pharmaceutical agents |
| 01/18/2007 | US20070015218 A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide |
| 01/18/2007 | US20070014876 Synergistic compositions and method for potentiating anti-oxidative activity |
| 01/18/2007 | US20070014807 Multiplex vaccine |
| 01/18/2007 | US20070014791 Rage-related methods and copositions for treating glomerular injury |
| 01/18/2007 | US20070014786 Methods for treating taxol-induced gut disorder |
| 01/18/2007 | US20070014749 Novel base material for pharmaceutical and/or cosmetic cream (herbal composition for itchy or infected skin) |
| 01/18/2007 | US20070014731 Vesicles comprising a flexible non-proteinaceous amphiphilic polymer capable of forming gas-containing vesicles; enhanced echocardiographic imaging |
| 01/18/2007 | US20070011904 Process for co-spray drying agents with dry silicified MCC |
| 01/17/2007 | EP1743657A2 Stabilisation of macrolides |
| 01/17/2007 | EP1742613A2 Crosslinked amine polymers |
| 01/17/2007 | EP1309547B1 Crystalline and pure modafinil, and process of preparing the same |
| 01/17/2007 | CN1897974A Medicinal lipolysis of accumulations of fat |
| 01/17/2007 | CN1897957A Chaperone-based therapy for niemann-pick disease |
| 01/17/2007 | CN1897956A Methods and compositions comprising thalidomide for treatment of fibromyalgia |
| 01/17/2007 | CN1897948A Alkoxy substituted imidazoquinolines |
| 01/17/2007 | CN1897947A Muscarinic acetylcholine receptor antagonists field of the invention |
| 01/17/2007 | CN1897945A Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 01/17/2007 | CN1897937A 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 01/17/2007 | CN1897919A Stabilized formulations of phosphatidylserine |
| 01/17/2007 | CN1897816A Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
| 01/17/2007 | CN1897812A Glycopegylated granulocyte colony stimulating factor |
| 01/17/2007 | CN1896088A C－芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors |
| 01/17/2007 | CN1896077A Synthesis and purification of valacyclovir |
| 01/16/2007 | US7164017 Exhibit electrophysiological activity |
| 01/16/2007 | US7163929 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/16/2007 | US7163920 Peptide with osteogenic activity |
| 01/16/2007 | CA2279093C Composition containing an opaque or pearling agent and at least one fatty alcohol |
| 01/11/2007 | WO2004091508A3 Fullerene compositions for ameliorating dermatological conditions |
| 01/11/2007 | US20070010746 Treatment of age-related macular degeneration |
| 01/11/2007 | US20070010574 Use of a trpm8-activating substance for the treatment of tumours |
| 01/11/2007 | US20070010571 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 01/11/2007 | US20070010548 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 01/11/2007 | US20070010508 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders |
| 01/11/2007 | US20070010505 Methods of treating disease states using antiangiogenic agents |
| 01/11/2007 | US20070010484 Method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration and method for promoting neurogenesis |
| 01/11/2007 | US20070010450 Hypertension, salt dependent high blood pressure, hepatic edema and liver cirrhosis; administering a hypotensive, antiedemic, and anticholesterol polypeptide that activates the guanylate cyclase receptor |
| 01/11/2007 | US20070010449 Administering Nematode-Extracted Anticoagulant Protein to treat viral hemorrhagic fever caused by a Filovirus, Arenavirus, Bunyavirus or Flavirus. |
| 01/11/2007 | US20070010435 Method for treating amyloid disease |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010027 Using ammonia to detect leaks in illegal drugs by evaporation and staining |
| 01/11/2007 | US20070010001 Improved bacteriophage compositions comprising specific sugars that reduce or abolish the bacterial phage-neutralizing activity; used to treat infectious diseases |
| 01/11/2007 | US20070009605 Encapsulation of water soluble peptides |
| 01/11/2007 | US20070009569 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance |
| 01/11/2007 | US20070009552 Simultaneous protection against each of the four dengue viruses, thereby precluding the possibility of developing the more serious illnesses dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), which occur in humans during secondary infection with a heterotypic wild-type dengue virus |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009510 Monoclonal antibodies against ricin toxin and methods of making and using thereof |
| 01/11/2007 | US20070009499 Myoblast treatment of diseased or weakened organs |
| 01/11/2007 | US20070009455 Whitening and antionxidative cosmetic composition containing resveratrol and method for preparing the same |
| 01/11/2007 | US20070006396 Composition for dyeing keratin fibers with a cationic direct dye and a thickening polymer |
| 01/10/2007 | EP1741777A1 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/10/2007 | EP1741426A2 Melt-extruded orally administrable opioid formulations |
| 01/10/2007 | EP1740552A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 01/10/2007 | EP1453505A4 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894275A Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |